Ketoeasy Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, which helps to reduce the accumulation of nitrogenous waste products in patients with impaired renal function. By providing these ketoanalogues, Ketoeasy Tablet supports protein metabolism while minimizing the production of uremic toxins, thereby alleviating the metabolic burden on compromised kidneys. This medication is typically prescribed as an adjunct to a low-protein diet to slow the progression of renal insufficiency and delay the need for dialysis. Ketoeasy Tablet is indicated for patients with moderate to severe CKD who require nutritional intervention to maintain adequate protein intake without exacerbating azotemia. The tablet should be administered under medical supervision, with dosage tailored according to the patient’s renal status and dietary regimen. Adherence to prescribed dietary restrictions and regular monitoring of renal function are essential to optimize therapeutic outcomes. Ketoeasy Tablet is contraindicated in patients with hypersensitivity to its components and should be used cautiously in those with hepatic impairment. Common side effects are rare but may include gastrointestinal disturbances.